SciVision Biotech Inc
TWSE:1786
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Risen Energy Co Ltd
SZSE:300118
|
CN |
SciVision Biotech Inc
Total Current Assets
SciVision Biotech Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SciVision Biotech Inc
TWSE:1786
|
Total Current Assets
NT$1.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Total Current Assets
$77.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Total Current Assets
NT$2.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pegavision Corp
TWSE:6491
|
Total Current Assets
NT$6.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Total Current Assets
NT$1.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
See Also
What is SciVision Biotech Inc's Total Current Assets?
Total Current Assets
1.4B
TWD
Based on the financial report for Dec 31, 2025, SciVision Biotech Inc's Total Current Assets amounts to 1.4B TWD.
What is SciVision Biotech Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
10%
Over the last year, the Total Current Assets growth was 22%. The average annual Total Current Assets growth rates for SciVision Biotech Inc have been 17% over the past three years , 21% over the past five years , and 10% over the past ten years .
